Evidence map›Paper›PMID 33931055›Full record

ArticleBMC public health2021

Individually optimal choices can be collectively disastrous in COVID-19 disease control.

Madison Stoddard, Debra Van Egeren, Kaitlyn E Johnson, Smriti Rao, Josh Furgeson, Douglas E White, Ryan P Nolan, Natasha Hochberg, Arijit Chakravarty

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 1 country.

Madison StoddardFractal Therapeutics, Cambridge, MA, USA.
Debra Van EgerenDepartment of Systems Biology, Harvard Medical School, Boston, MA, USA.
Kaitlyn E JohnsonDepartment of Biomedical Engineering, University of Texas, Austin, TX, USA.
Smriti RaoDepartment of Economics, Assumption College, Worcester, MA, USA.
Josh FurgesonInternational Initiative for Impact Evaluation, Cambridge, MA, USA.
Douglas E WhiteGeorgia Institute of Technology, Atlanta, GA, USA.
Ryan P NolanHalozyme Therapeutics, San Diego, CA, USA.
Natasha HochbergBoston Medical Center, Boston, MA, USA.
Arijit ChakravartyFractal Therapeutics, Cambridge, MA, USA. arijit@fractaltx.com.
Assumption College · USBoston Medical Center · USGeorgia Institute of Technology · USHalozyme Therapeutics (United States) · USHarvard University · USInternational Initiative for Impact Evaluation · USThe University of Texas at Austin · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe word 'pandemic' conjures dystopian images of bodies stacked in the streets and societies on the brink of collapse. Despite this frightening picture, denialism and noncompliance with public health measures are common in the historical record, for example during the 1918 Influenza pandemic or the 2015 Ebola epidemic. The unique characteristics of SARS-CoV-2-its high basic reproduction number (R

methodsIn this work, we used game theory to explore when noncompliance confers a perceived benefit to individuals. We then used epidemiological modeling to predict the impact of noncompliance on control of SARS-CoV-2, demonstrating that the presence of a noncompliant subpopulation prevents suppression of disease spread.

resultsOur modeling demonstrates that noncompliance is a Nash equilibrium under a broad set of conditions and that the existence of a noncompliant population can result in extensive endemic disease in the long-term after a return to pre-pandemic social and economic activity. Endemic disease poses a threat for both compliant and noncompliant individuals; all community members are protected if complete suppression is achieved, which is only possible with a high degree of compliance. For interventions that are highly effective at preventing disease spread, however, the consequences of noncompliance are borne disproportionately by noncompliant individuals.

conclusionsIn sum, our work demonstrates the limits of free-market approaches to compliance with disease control measures during a pandemic. The act of noncompliance with disease intervention measures creates a negative externality, rendering suppression of SARS-CoV-2 spread ineffective. Our work underscores the importance of developing effective strategies for prophylaxis through public health measures aimed at complete suppression and the need to focus on compliance at a population level.

Indexed as

COVID-19Influenza, HumanHumansMasksPandemicsSARS-CoV-2COVID-19Epidemiological modelingGame theoryInfectious disease controlSARS-CoV-2Vaccine hesitancy

Identifiers

PMID33931055
PMCPMC8085805
OpenAlexW3126220332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.